However, some researchers in Korea did not find a positive association between ERCC1 polymorphisms and cervical cancer by evaluating the peripheral blood through the PCR restriction fragment length polymorphism assay in 229 invasive cervical cancer patients and 204 non-cancer controls (33). This evidence concerns the gene ERCC1 and cervical carcinoma.